FOX vs ZYME · P/E 13, rev $16.30B vs rev $76.3M
Fox Corp Class B (FOX) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the FOX and ZYME stock pages for the full models.
Not investment advice.